FTO-mediated LINC01134 stabilization to promote chemoresistance through miR-140-3p/WNT5A/WNT pathway in PDAC

Jin Lu1, Yongsheng Yang2, Xiangliang Liu1

  • 1Cancer Center, The First Hospital of Jilin University, 71 Xinmin Street, Changchun, 130021, China.

Cell Death & Disease
|November 2, 2023
PubMed

Insights

Pancreatic cancer (PDAC) resistance to gemcitabine (GEM) chemotherapy is a major challenge. This study reveals LINC01134 promotes GEM resistance by enhancing stemness and cell cycle modulation, offering new therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer often diagnosed at late stages, limiting treatment efficacy.
  • Gemcitabine (GEM) is the first-line chemotherapy for PDAC, but resistance significantly hinders clinical outcomes.
  • Lack of effective biomarkers for gemcitabine resistance necessitates the identification of novel prognostic markers and therapeutic targets.

Purpose of the Study:

  • To elucidate a novel regulatory mechanism driving gemcitabine resistance in pancreatic ductal adenocarcinoma.
  • To identify LINC01134 as a potential biomarker and therapeutic target for overcoming chemotherapy resistance in PDAC.

Main Methods:

  • Analysis of LINC01134 expression in PDAC patient tumors.
  • In vitro and in vivo functional studies to assess the role of LINC01134 in gemcitabine resistance.
  • Investigation of the molecular mechanisms involving microRNAs (miR-497-5p, miR-140-3p), WNT5A, and FTO.

Main Results:

  • LINC01134 was significantly upregulated in PDAC tumors.
  • LINC01134 promotes PDAC gemcitabine resistance by enhancing stem cell features and modulating the cell cycle.
  • LINC01134 downregulates miR-140-3p, leading to increased oncogenic WNT5A expression.
  • FTO-mediated stabilization of LINC01134 contributes to gemcitabine resistance via the miR-140-3p/WNT5A/WNT pathway.

Conclusions:

  • FTO-mediated stabilization of LINC01134 is a key mechanism promoting gemcitabine resistance in PDAC.
  • LINC01134, regulated by FTO, represents a promising prognostic marker and therapeutic target for PDAC patients.
  • Targeting the FTO-LINC01134-miR-140-3p-WNT5A axis could offer new strategies to overcome gemcitabine resistance in pancreatic cancer.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.8K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.3K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K